Silence Therapeutics (SLN) Other Non Operating Income (2024 - 2026)
Silence Therapeutics (SLN) reported Other Non Operating Income of -$482000.0 for Q1 2026, up 87.21% on a YoY basis from -$257462.9 in Q1 2025, and down 154.77% sequentially from $880000.0 in Q4 2025.
Silence Therapeutics (SLN) Other Non Operating Income (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Other Non Operating Income data on file, last reported at -$482000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 87.21% year-over-year to -$482000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 84.58% YoY), and the FY2025 full-year result was $3.5 million, down 22.18% from the prior year.
- Other Non Operating Income eased to -$482000.0 in Q1 2026, from $880000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $15.7 million in Q4 2024 to a low of -$3.8 million in Q1 2025.
- A 3-year average of $1.8 million and a median of $770000.0 in 2025 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 487.84% in 2025, while the deepest fall reached 665.07% in 2025.
- Tracing SLN's Other Non Operating Income over 3 years: stood at $15.7 million in 2024, then slumped by 94.41% to $880000.0 in 2025, then sank by 154.77% to -$482000.0 in 2026.
- Business Quant data shows SLN's Other Non Operating Income at -$482000.0 in Q1 2026, $880000.0 in Q4 2025, and $770000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -482,000.00 |
| Dec 31, 2025 | 880,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | 861,000.00 |
| Mar 31, 2025 | -3.77 Mn |
| Dec 31, 2024 | 15.74 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | -222,000.00 |
| Mar 31, 2024 | 667,000.00 |